Polmacoxib
- Generic Name
- Polmacoxib
- Drug Type
- Small Molecule
- Chemical Formula
- C18H16FNO4S
- CAS Number
- 301692-76-2
- Unique Ingredient Identifier
- IJ34D6YPAO
- Background
Polmacoxib has been used in trials studying the treatment of Osteoarthritis, Osteoarthritis, Hip, Osteoarthritis, Knee, Localized Primary Osteoarthritis of Hip, and Localized Primary Osteoarthritis of Knee.
Drug-Drug Interaction Study of "CG-651" in Healthy Volunteer
- First Posted Date
- 2022-05-11
- Last Posted Date
- 2022-05-31
- Lead Sponsor
- CrystalGenomics, Inc.
- Target Recruit Count
- 47
- Registration Number
- NCT05370716
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Drug-Drug Interaction Study of "CG100650" in Healthy Volunteers
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2018-12-14
- Last Posted Date
- 2022-05-27
- Lead Sponsor
- CrystalGenomics, Inc.
- Target Recruit Count
- 41
- Registration Number
- NCT03775629
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Study to Compare Safety and Pharmacokinetics of "CG1801" and "CGL1802" in Healthy Volunteers
- First Posted Date
- 2018-12-12
- Last Posted Date
- 2019-09-25
- Lead Sponsor
- CrystalGenomics, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT03774355
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Phase III Study of CG100649 in Osteoarthritis Patients
- Conditions
- Localized Primary Osteoarthritis of KneeLocalized Primary Osteoarthritis of Hip
- Interventions
- First Posted Date
- 2013-01-10
- Last Posted Date
- 2023-02-15
- Lead Sponsor
- CrystalGenomics, Inc.
- Target Recruit Count
- 362
- Registration Number
- NCT01765296
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
🇰🇷Chungnam National University Hospital, Daejeon, Korea, Republic of
🇰🇷NHIC Ilsan Hospital, Goyang-si, Korea, Republic of
Study of CG100649 Versus Celecoxib in Osteoarthritis Patients
- First Posted Date
- 2011-04-25
- Last Posted Date
- 2023-02-09
- Lead Sponsor
- CrystalGenomics, Inc.
- Target Recruit Count
- 125
- Registration Number
- NCT01341405
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Trial for Studying Pharmacokinetic Effects of Ketoconazole on CG100649
- First Posted Date
- 2010-07-01
- Last Posted Date
- 2024-01-03
- Lead Sponsor
- CrystalGenomics, Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT01154764
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Phase I Study on Multiple Oral Dosing of CG100649
- First Posted Date
- 2010-07-01
- Last Posted Date
- 2016-01-28
- Lead Sponsor
- CrystalGenomics, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT01154790
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Phase II Study of CG100649 for Primary Osteoarthritis in Male Subjects
- Conditions
- Osteoarthritis, KneeOsteoarthritis, Hip
- Interventions
- First Posted Date
- 2007-09-17
- Last Posted Date
- 2008-06-13
- Lead Sponsor
- CrystalGenomics, Inc.
- Target Recruit Count
- 240
- Registration Number
- NCT00530452
- Locations
- 🇩🇪
Orthopaedische Praxis, Bad Dürrheim, Baden-Württemberg, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.